WINTER SPRINGS, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ:IRMD) today announced that the Company will be participating in two upcoming investor conferences.
Iradimed management is scheduled to participate in investor meetings at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday and Wednesday, September 12-13, 2023, at the Lotte New York Palace Hotel in New York City. Iradimed management will also be participating in investor meetings at the Lake St. Capital 7th Annual Best Ideas Growth Conference "Big7" on Thursday, September 14 at the Yale Club in New York City.
About IRADIMED CORPORATION
IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging ("MRI") compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services.
We are the only provider of a non-magnetic intravenous ("IV") infusion pump system designed to be safe ...